CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 251 filers reported holding CANTEL MEDICAL CORP in Q3 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
Q1 2020 | $8,156,000 | -66.8% | 227,182 | -34.5% | 0.14% | -56.1% |
Q4 2019 | $24,579,000 | -26.4% | 346,662 | -22.3% | 0.33% | -30.2% |
Q3 2019 | $33,385,000 | +0.4% | 446,327 | +8.2% | 0.47% | -6.9% |
Q2 2019 | $33,263,000 | +18.1% | 412,486 | -2.0% | 0.50% | +11.2% |
Q1 2019 | $28,157,000 | +6.4% | 420,943 | +18.4% | 0.45% | -13.0% |
Q4 2018 | $26,474,000 | -9.8% | 355,591 | +11.6% | 0.52% | +10.6% |
Q3 2018 | $29,339,000 | -6.9% | 318,689 | -0.5% | 0.47% | -8.5% |
Q2 2018 | $31,499,000 | -12.5% | 320,240 | -0.9% | 0.52% | -15.1% |
Q1 2018 | $36,016,000 | +7.9% | 323,272 | -0.4% | 0.61% | +6.7% |
Q4 2017 | $33,389,000 | -8.0% | 324,579 | -15.8% | 0.57% | -5.8% |
Q3 2017 | $36,291,000 | +20.5% | 385,375 | -0.3% | 0.60% | +16.3% |
Q2 2017 | $30,121,000 | -5.7% | 386,609 | -3.1% | 0.52% | -13.5% |
Q1 2017 | $31,942,000 | +0.2% | 398,772 | -1.5% | 0.60% | -3.2% |
Q4 2016 | $31,878,000 | -11.9% | 404,799 | -12.7% | 0.62% | -8.5% |
Q3 2016 | $36,177,000 | +11.6% | 463,923 | -1.6% | 0.68% | +1.5% |
Q2 2016 | $32,416,000 | -7.0% | 471,645 | -3.4% | 0.67% | -13.3% |
Q1 2016 | $34,841,000 | +12.3% | 488,240 | -2.2% | 0.77% | +6.0% |
Q4 2015 | $31,014,000 | +5.9% | 499,103 | -3.4% | 0.73% | +4.1% |
Q3 2015 | $29,293,000 | +7.6% | 516,640 | +1.9% | 0.70% | +12.9% |
Q2 2015 | $27,215,000 | +9.7% | 507,087 | -2.9% | 0.62% | +9.8% |
Q1 2015 | $24,811,000 | +8.6% | 522,334 | -1.1% | 0.56% | +3.3% |
Q4 2014 | $22,844,000 | +25.1% | 528,059 | -0.5% | 0.55% | +14.0% |
Q3 2014 | $18,254,000 | -5.1% | 530,937 | +1.1% | 0.48% | -1.6% |
Q2 2014 | $19,233,000 | +14.5% | 525,213 | +5.4% | 0.49% | +8.2% |
Q1 2014 | $16,798,000 | -0.4% | 498,153 | +0.2% | 0.45% | -2.0% |
Q4 2013 | $16,858,000 | +124.7% | 497,143 | +111.0% | 0.46% | +100.4% |
Q3 2013 | $7,503,000 | – | 235,588 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DIKER MANAGEMENT LLC | 1,084,317 | $85,509,000 | 43.23% |
Leonard Green & Partners, L.P. | 2,100,000 | $165,606,000 | 2.29% |
Champlain Investment Partners, LLC | 3,952,620 | $311,704,000 | 1.79% |
Brown Capital Management | 2,454,770 | $193,583,000 | 1.34% |
Aurora Investment Counsel | 19,502 | $1,538,000 | 1.24% |
Conestoga Capital Advisors, LLC | 797,481 | $62,889,000 | 1.00% |
EMERALD ADVISERS, LLC | 292,554 | $23,071,000 | 0.77% |
FRED ALGER MANAGEMENT, LLC | 3,470,340 | $273,671,000 | 0.71% |
GENEVA CAPITAL MANAGEMENT LLC | 510,171 | $40,232,000 | 0.68% |
WASHINGTON CAPITAL MANAGEMENT, INC | 7,650 | $603,000 | 0.58% |